Drug intelligence / Profile preview

paper mulberry leaf

Development stage
Phase 2
Lead developer
China Medical University Hospital
Administration
Oral, Topical
01

Overview

Paper mulberry leaf, derived from the plant *Broussonetia papyrifera*, is an herbal medicine investigated for its therapeutic properties. [1] It has a long history of use in Traditional Chinese Medicine to treat conditions such as skin disorders, with reputed effects to "clear heat, cool blood and relieve itching". [12] The leaf extract contains various bioactive compounds, including flavonoids, phenols, and alkaloids, which are believed to contribute to its medicinal effects. [1, 2, 3, 6] Preclinical research in mouse models of psoriasis suggests that paper mulberry leaf extract exerts anti-inflammatory and antioxidant effects. [4, 5, 7] Its mechanism may involve the inhibition of inflammatory signaling pathways such as TLR4/NF-κB and PI3K/AKT, leading to a reduction in pro-inflammatory cytokines like TNF-α, IL-6, and IL-17A. [4, 5, 7] A pilot clinical trial at China Medical University Hospital is evaluating a medicated bath formulation containing paper mulberry leaf, known as Jing-Fu-Yau-Yu-Bau, as a complementary therapy for patients with mild to moderate plaque-type psoriasis.

Brand names
Jing-Fu-Yau-Yu-Bau
Other names
Broussonetia papyrifera leaf
02

Targets

NF-κBTLR4 (Toll-like receptor 4)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)AKT (RAC-alpha serine/threonine-protein kinase)

Beyond the preview

Go deeper on paper mulberry leaf.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paper mulberry leaf.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call